You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand

May 2011

Price: $900

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in New Zealand with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in New Zealand, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand?
  • What are the major brands in New Zealand?
  • What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

TRENDS

  • The classification of pseudoephedrine containing medicines was under review and received a lot of media attention in 2009 and 2010. Ephedrine and pseudoephedrine are active ingredients used in the manufacture of the class A controlled drug methamphetamine. Pseudoephedrine is currently available over the counter in cold and flu remedies from pharmacies. The reclassifications will make both ephedrine and pseudoephedrine prescription-only. The review is in accordance with the October 2009 announcement by Prime Minister John Key regarding the government’s action plan to decrease the negative effects in New Zealand of the highly addictive and harmful drug, known as P. During June 2009 the Expert Advisory Committee on Drugs determined that legislative change was required on the grounds that effective alternative remedies to ephedrine and pseudoephedrine are available, and that the risk of pseudoephedrine being diverted into the manufacture of methamphetamine outweighs the requirement for its on-going over-the-counter availability. Therefore, the purpose of the reclassifications is to restrict the availability of these substances and make it difficult for potential manufacturers of methamphetamine to access the key ingredients required to make the drug. Demand and supply of pseudoephedrine-containing medicines both reduced further in 2010.

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser New Zealand Ltd continued to dominate the category in 2010, with a retail value share of 28%, up half a percentage point from 2009. The company’s Lemsip, Strepsils and Nurofen brands continue to perform well, keeping up with consumer trends through innovation and marketing. These are underpinned by high levels of advertising and promotion, which bolster high brand awareness among consumers. The Lemsip brand held the highest brand share in 2010, with 15% of sales.

PROSPECTS

  • From 1 May 2011, cough and cold medicines for children under 12 years of age which contain dextromethorphan and phenylephrine will become pharmacy-only products. Products containing these ingredients may only be sold outside pharmacies from 1 May 2011, if they are re-labelled for use in adults and children over 12 years of age. The Pharmacy Guild believes that reclassification will significantly increase the safety and effectiveness of treatment for patients suffering coughs and colds. However, the New Zealand Self-Medication Industry Association believes that it will reduce access and availability for consumers to these products and will increase costs for suppliers and thus consumers.

Table of Contents

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand - Category Analysis

HEADLINES

TRENDS

  • The classification of pseudoephedrine containing medicines was under review and received a lot of media attention in 2009 and 2010. Ephedrine and pseudoephedrine are active ingredients used in the manufacture of the class A controlled drug methamphetamine. Pseudoephedrine is currently available over the counter in cold and flu remedies from pharmacies. The reclassifications will make both ephedrine and pseudoephedrine prescription-only. The review is in accordance with the October 2009 announcement by Prime Minister John Key regarding the government’s action plan to decrease the negative effects in New Zealand of the highly addictive and harmful drug, known as P. During June 2009 the Expert Advisory Committee on Drugs determined that legislative change was required on the grounds that effective alternative remedies to ephedrine and pseudoephedrine are available, and that the risk of pseudoephedrine being diverted into the manufacture of methamphetamine outweighs the requirement for its on-going over-the-counter availability. Therefore, the purpose of the reclassifications is to restrict the availability of these substances and make it difficult for potential manufacturers of methamphetamine to access the key ingredients required to make the drug. Demand and supply of pseudoephedrine-containing medicines both reduced further in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser New Zealand Ltd continued to dominate the category in 2010, with a retail value share of 28%, up half a percentage point from 2009. The company’s Lemsip, Strepsils and Nurofen brands continue to perform well, keeping up with consumer trends through innovation and marketing. These are underpinned by high levels of advertising and promotion, which bolster high brand awareness among consumers. The Lemsip brand held the highest brand share in 2010, with 15% of sales.

PROSPECTS

  • From 1 May 2011, cough and cold medicines for children under 12 years of age which contain dextromethorphan and phenylephrine will become pharmacy-only products. Products containing these ingredients may only be sold outside pharmacies from 1 May 2011, if they are re-labelled for use in adults and children over 12 years of age. The Pharmacy Guild believes that reclassification will significantly increase the safety and effectiveness of treatment for patients suffering coughs and colds. However, the New Zealand Self-Medication Industry Association believes that it will reduce access and availability for consumers to these products and will increase costs for suppliers and thus consumers.

CATEGORY DATA

  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 3 Sales of Decongestants by Category: Value 2005-2010
  • Table 4 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 5 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 6 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand - Company Profiles

Vitaco Health Ltd in Consumer Health (New Zealand)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 2 Vitaco Health Ltd: Competitive Position 2010

Consumer Health in New Zealand - Industry Context

EXECUTIVE SUMMARY

Consumer health remains strong during economic downturn

Changes in consumer buying behaviour

Vitaco Health Ltd maintains number one position

Internet retailing sees significant growth

Forecast period growth expected

KEY TRENDS AND DEVELOPMENTS

Christchurch earthquake implications

  • Table 11 Economic Projections 2011

Tobacco smoking declines

Natural healing and prevention

Private label and generics

Self-medication on the Increase

Competition intensifies among manufacturers and retailers

MARKET INDICATORS

  • Table 12 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 13 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 14 Sales of Consumer Health by Category: Value 2005-2010
  • Table 15 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 16 Consumer Health Company Shares by Value 2006-2010
  • Table 17 Consumer Health Brand Shares by Value 2007-2010
  • Table 18 Penetration of Private Label by Category 2005-2010
  • Table 19 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 20 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 21 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 22 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 3 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 4 Research Sources

Segmentation

Segmentation

This market research report includes the following:

  • Cough, Cold and Allergy (Hay Fever) Remedies
    • Antihistamines/Allergy Remedies (Systemic)
    • Child-Specific Cough, Cold and Allergy Remedies
      • Child-Specific Allergy Remedies
      • Child-Specific Cough/Cold Remedies
    • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
    • Cough Remedies
    • Decongestants
      • Nasal Sprays
      • Oral Decongestants
      • Inhalant Decongestants
      • Decongestant Rubs
      • Nasal Decongestant Drops
      • Nasal Decongestant Plasters
    • Medicated Confectionery
    • Pharyngeal Preparations

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking incidence

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report